Rebecca Arden Harris, MD, MSc
Assistant Professor of Family Medicine and Community Health at the Hospital of the University of Pennsylvania
Attending Physician, Penn Presbyterian Medical Center
Senior Fellow, Leonard Davis Institute of Health Economics
Department: Family Medicine and Community Health
Contact information
Penn Family Care
3737 Market Street, 9th Floor
Philadelphia, PA 19104
3737 Market Street, 9th Floor
Philadelphia, PA 19104
Links
Google Scholar page
Institute for Translational Medicine and Therapeutics bio
LDI Senior Fellow bio
Google Scholar page
Institute for Translational Medicine and Therapeutics bio
LDI Senior Fellow bio
Education:
BSc (Biology)
Haverford College, 2008.
MD (Medicine)
Jefferson Medical College, Thomas Jefferson University, 2013.
MSc (Health Policy Research)
University of Pennsylvania, 2021.
Permanent linkBSc (Biology)
Haverford College, 2008.
MD (Medicine)
Jefferson Medical College, Thomas Jefferson University, 2013.
MSc (Health Policy Research)
University of Pennsylvania, 2021.
Description of Research Expertise
Dr. Harris' research centers on opioid prescribing, substance use disorders, treatment delivery and innovation in primary care, cost modeling, and the evaluation of national drug policy initiatives.Selected Publications
Harris RA, Long JA, Bao Y, Mandell DS: Racial, Ethnic, and Sex Differences in Methadone-Involved Overdose Deaths Before and After the US Federal Policy Change Expanding Take-home Methadone Doses. JAMA Health Forum 4(6), June 2023.Harris RA, Mandell DS: Years of Life Lost to Drug Overdose in the Latinx Community During the Most Recent Wave of Overdose Deaths. American Journal on Addictions August 2023.
Harris RA, Mandell DS: Years of Life Lost to Drug Overdose Among Black Female Individuals in the US, 2015-2021. JAMA Psychiatry December 2022.
Harris RA, Mandell DS. : Fatal drug overdose among middle-aged Black men: A life table analysis. Addictive Behaviors 144, April 2023 Notes: doi: 10.1016/j.addbeh.2023.107743.
Harris RA: Drug overdose deaths among non-Hispanic Black men in the US: Age-specific projections through 2025. AJPM Focus 2(1), March 2023 Notes: in press.
Harris RA: Sex and drug overdose mortality trends, 1999-2020 JAMA Psychiatry July 2022.
Harris RA, Campbell K, Calderbank T, Dooley P, Aspero H, Maginnis J, O’Donnell N, Coviello D, French R, Bao Y, Mandell DS, Bogner HR, Lowenstein M.: Integrating peer support services into primary care-based OUD treatment: Lessons from the Penn integrated model. HealthCare: The Journal of Delivery Science and Innovation September 2022.
Harris RA: Race, overdose deaths, and years of lost life. JAMA Pediatrics May 2022.
Harris RA, Mandell DS, Gross R: A national opioid tax is a promising way to raise revenue for treatment programs, but there are problems. JAMA Health Forum January 2022.
Harris RA, Aronowitz S, French R, Mandell DS.: It’s time for Pa. to stop allowing overdose deaths to be treated like homicides. The Philadelphia Inquirer December 2021.
Harris RA, Mandell DS, Kampman KM, Bao Y, Campbell K, Cidav Z, Coviello DM, French R, Livesey C, Lowenstein M, Lynch KG, McKay JR, Oslin DW, Wolk CB, Bogner HR: Collaborative care in the treatment of opioid use disorder and mental health conditions in primary care: A clinical study protocol. Contemporary Clinical Trials April 2021.
Harris RA, Kanzler HR, Chang K-M, Doubeni CA, Gross R.: Long-term use of hydrocodone vs. oxycodone in primary care. Drug and Alcohol Dependence 205, Epub 2019 Nov 2 2019.
Harris RA: Prescription opioid type and the likelihood of prolonged opioid use after orthopaedic surgery. Journal of the American Academy of Orthopaedic Surgeons 27(9): 423-429, May 2019.
Harris RA, Xue X, Selwyn PA.: Housing stability and medication adherence among HIV-positive individuals in antiretroviral therapy: A meta-analysis of observational studies in the U.S. Journal of Acquired Immune Deficiency Syndromes 74(3): 309-317, March 2017.
Harris RA, Haberer JE, Musinguzi N, Chang KM, Schechter CB, Doubeni CA, Gross R: Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model. PLoS ONE 13(3): e0194713, 2018.